REPORT ON TAMDEFLO AT NGUYỄN TRI PHƯƠNG HOSPITAL

On June 30, 2025, Medbolide Pharmaceutical JSC held a presentation introducing Tamdeflo (deflazacort 6 mg) at the Department of Orthopedics and Rheumatology of Nguyen Tri Phuong Hospital.

The presentation was attended by 30 doctors and healthcare professionals.

Company representatives presented guidelines and clinical studies demonstrating the benefits of deflazacort in treating conditions responsive to corticosteroids and minimizing the side effects of corticosteroids.

Following the presentation, the doctors engaged in a lively discussion regarding the drug’s usage and safety.

At the conclusion of the presentation, Medbolide expressed its gratitude and looked forward to continuing to partner with the hospital in providing solutions that improve patients’ quality of life.